home · filing · 0001193125-24-260405
8-K filed November 18, 2024, 6:59 PM ET
ticker CVS
CIK 0000064803
other material
confidence high
sentiment positive
materiality 0.70
CVS Health adds four directors, enters pact with Glenview Capital; CEO pay raised
CVS HEALTH Corp
Board expanded from 12 to 16 with appointments of Leslie Norwalk, Larry Robbins, Guy Sansone, Doug Shulman.
Glenview Capital (Larry Robbins) gets board seats; standstill until 30 days before 2026 director nomination window.
CEO David Joyner's total direct compensation raised to $19M/yr ($1.5M base, $3M bonus target, $14.5M LTI).
Prem Shah (EVP Group President) gets $1.1M base, $1.925M bonus target, $9M LTI; one-time option award $6M.
Tilak Mandadi receives $3M in time-vesting RSUs as retention award; vests over three years.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Larry Robbins
Director
Effective 2024-11-17
Filed November 18, 2024, 6:59 PM ET
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
Appointed
Doug Shulman
Director
Effective 2024-11-17
Filed November 18, 2024, 6:59 PM ET
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
Appointed
Guy Sansone
Director
Effective 2024-11-17
Filed November 18, 2024, 6:59 PM ET
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
Appointed
Leslie Norwalk
Director
Effective 2024-11-17
Filed November 18, 2024, 6:59 PM ET
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Larry Robbins was appointed as Director at CVS HEALTH Corp.
Action appointed
Role Director
Exact text from the filing
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Doug Shulman was appointed as Director at CVS HEALTH Corp.
Action appointed
Role Director
Exact text from the filing
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Guy Sansone was appointed as Director at CVS HEALTH Corp.
Action appointed
Role Director
Exact text from the filing
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Leslie Norwalk was appointed as Director at CVS HEALTH Corp.
Action appointed
Role Director
Exact text from the filing
On November 17, 2024, Ms. Norwalk, Mr. Robbins, Mr. Sansone and Mr. Shulman were appointed to the Board.
View on SEC.gov
Source: SEC EDGAR
accession 0001193125-24-260405
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.